<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Girard TJ</submitter><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>629-638</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9773443</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with excessive coagulation, thrombosis, and mortality.&lt;h4>Objective&lt;/h4>To provide insight into mechanisms that contribute to excessive coagulation in coronavirus 2019 (COVID-19) disease.&lt;h4>Patients/methods&lt;/h4>Blood from COVID-19 patients was investigated for coagulation-related gene expression and functional activities.&lt;h4>Results&lt;/h4>Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from severe COVID-19 patients revealed a 5.2-fold increase in tissue factor (TF [F3 gene]) transcript expression levels (P &lt; .05), the trigger of extrinsic coagulation; a 7.7-fold increase in C1-inhibitor (SERPING1 gene; P &lt; .01) transcript expression levels, an inhibitor of int</pubmed_abstract><journal>Journal of thrombosis and haemostasis : JTH</journal><pubmed_title>Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.</pubmed_title><pmcid>PMC9773443</pmcid><funding_grant_id>P30 CA091842</funding_grant_id><funding_grant_id>UL1 TR002345</funding_grant_id><funding_grant_id>R01 HL120728</funding_grant_id><funding_grant_id>R61 HL141794</funding_grant_id><funding_grant_id>R37 AI049653</funding_grant_id><pubmed_authors>Randolph GJ</pubmed_authors><pubmed_authors>Di Paola J</pubmed_authors><pubmed_authors>Antunes L</pubmed_authors><pubmed_authors>Steed AL</pubmed_authors><pubmed_authors>Girard TJ</pubmed_authors><pubmed_authors>Eldem I</pubmed_authors><pubmed_authors>Erlich EC</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors><pubmed_authors>Mazer M</pubmed_authors><pubmed_authors>Cruchaga C</pubmed_authors><pubmed_authors>Remy KE</pubmed_authors><pubmed_authors>Subramanian R</pubmed_authors><pubmed_authors>Amrute JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.</name><description>&lt;h4>Background&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with excessive coagulation, thrombosis, and mortality.&lt;h4>Objective&lt;/h4>To provide insight into mechanisms that contribute to excessive coagulation in coronavirus 2019 (COVID-19) disease.&lt;h4>Patients/methods&lt;/h4>Blood from COVID-19 patients was investigated for coagulation-related gene expression and functional activities.&lt;h4>Results&lt;/h4>Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from severe COVID-19 patients revealed a 5.2-fold increase in tissue factor (TF [F3 gene]) transcript expression levels (P &lt; .05), the trigger of extrinsic coagulation; a 7.7-fold increase in C1-inhibitor (SERPING1 gene; P &lt; .01) transcript expression levels, an inhibitor of int</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2026-05-28T19:00:37.262Z</modification><creation>2025-02-19T00:14:00.445Z</creation></dates><accession>S-EPMC9773443</accession><cross_references><pubmed>36696180</pubmed><doi>10.1016/j.jtha.2022.11.033</doi></cross_references></HashMap>